PortfolioProducts available |
||
| Myskin™ Myskin™ is the first product to be launched by CellTran for the active treatment of difficult to heal wounds. This is a ground-breaking treatment which offers ease of use for the benefit of both patient and medical professional. Click here to learn more about Myskin™. |
 |
|
| Products in clinical development |
||
| |
||
| Lyphoderm Lyphoderm is a freeze-dried total lysate from cultured human keratinocytes, formulated into a hydrophilic gel. These deliver a wide range of cytokines and growth factors at the wound site. Lyphoderm is being developed for topical treatment of chronic hard to heal venous skin ulcers. Lyphoderm has undergone phase II clinical testing in venous leg ulcers, and is due to enter phase III clinical trials in 2008. Click here to learn more about Lyphoderm. |
 |
|
| Ulcodress An integrated wound care dressing consisting of a gel sheet incorporating control of moisture, infection and proteases within the wound area. Ulcodress is currently undergoing a CE marking process, prior to launch. CellTran also has a pipeline of advanced wound care products in development. |
.jpg) |